• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2016 Fiscal Year Annual Research Report

CRISPR/Cas9封入高分子集合体の構築と生体内デリバリーへの挑戦

Research Project

Project/Area Number 16F16355
Research InstitutionThe University of Tokyo

Principal Investigator

宮田 完二郎  東京大学, 大学院工学系研究科(工学部), 准教授 (50436523)

Co-Investigator(Kenkyū-buntansha) MIN HYUN SU  東京大学, 大学院工学系研究科(工学部), 外国人特別研究員
Project Period (FY) 2016-10-07 – 2019-03-31
Keywords薬物送達システム / CRISPR / Cas9
Outline of Annual Research Achievements

In order to achieve the research theme of the Cas9 delivery for genomic correction, Duchenne muscular dystrophy (DMD) disease, which is caused by mutation in the gene encoding dystrophin, was selected as a target disease. First, single-strand guide RNA (sgRNA) was designed for the cleavage of target mutation region after complexation with Cas9 protein. In a cell-free experiment, the significant cleavage of dystrophin gene was observed using the designed sgRNA. Second, six types of cationic polymers were synthesized for the construction of polyion complexes (PICs) with Cas9-coding mRNA, as well as sgRNA. The successful PIC formation was confirmed by the size measurement. Finally, several PIC formulations elicited the significant mRNA expression in cultured C2C12 (Mus musculus muscle) cells.

Current Status of Research Progress
Current Status of Research Progress

2: Research has progressed on the whole more than it was originally planned.

Reason

1) The sgRNA was successfully designed for degradation of target dystrophin in genome, as evidenced by gel electrophoresis, where two cleavage sites of intron (22 and 23 intron) were observed after treatment with Cas9.
2) Thee types of N-substituted polyasparamide (PAsp) homopolymers, two types of poly(ethylene glycol) (PEG)-PAsp block copolymers, and PEG-polylysine block copolymer were successfully synthesized and applied for polyion complex (PIC) formation with RNA species. Among them, PAsp homopolymers and PEG-PAsp could form PICs with a diameter of ~100 nm with narrow size distributions.
3) The significant transfection efficiencies of the PICs prepared from PAsp homopolymers were observed for cultured C2C12 cells.

Strategy for Future Research Activity

For more efficient Cas9/sgRNA delivery, RNA-loaded PICs (or cationic polymers) are modified with hydrophobic moieties or lipids to enhance the complex stability and/or cellular uptake efficiency. The obtained PICs are evaluated for simultaneous loading of Cas9 mRNA and sgRNA. Then, they are tested for in vitro transfection against C2C12 cells to determine the genome editing activity.

  • Research Products

    (5 results)

All 2017 2016 Other

All Presentation (4 results) (of which Int'l Joint Research: 2 results,  Invited: 4 results) Remarks (1 results)

  • [Presentation] ナノマシンによるがん治療の最前線2017

    • Author(s)
      宮田完二郎
    • Organizer
      先端ナノデバイス・材料テクノロジー第151委員会
    • Place of Presentation
      川崎 川崎生命科学・環境研究センター
    • Year and Date
      2017-03-02 – 2017-03-02
    • Invited
  • [Presentation] Polymer-based oligonucleotide delivery ~challenges and solutions~2017

    • Author(s)
      Kanjiro Miyata
    • Organizer
      11th Annual Symposium on Nanobiotechnology 2017
    • Place of Presentation
      Kawasaki, Japan
    • Year and Date
      2017-02-27 – 2017-02-28
    • Int'l Joint Research / Invited
  • [Presentation] Development of smart polymeric nanocarriers for targeted siRNA delivery2016

    • Author(s)
      Kanjiro Miyata
    • Organizer
      EPFL/UTokyo Joint Symposium 2016, Lausanne
    • Place of Presentation
      Lausanne, Switzerland
    • Year and Date
      2016-12-05 – 2016-12-07
    • Int'l Joint Research / Invited
  • [Presentation] 高分子ナノキャリアを用いた核酸医薬デリバリー2016

    • Author(s)
      宮田完二郎
    • Organizer
      第1回RNA創薬セミナー
    • Place of Presentation
      大阪 大阪医科大学
    • Year and Date
      2016-10-31 – 2016-10-31
    • Invited
  • [Remarks] 宮田研究室ホームページ

    • URL

      http://www.bmm.t.u-tokyo.ac.jp/index.html

URL: 

Published: 2019-12-27  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi